Sofía Haselgruber-de Francisco

8PUBLICATIONS
18CO-AUTHORS
Toxicology (incl. clinical toxicology)Major global burdens of diseaseHealth informatics and information systemsSocial epidemiologyAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 15, 2026
Limited Effectiveness of IL-17 Inhibitors for Anti-TNF-Induced Psoriasis in Hidradenitis Suppurativa: A Multicenter Retrospective Study.

Leonardo Bascón, Juan José Lluch-Galcerá, Verónica Mora-Fernández

|Jun 18, 2025
The Microbiome in Hidradenitis Suppurativa Tunnels: A Systematic Review.

Alberto Soto-Moreno, Sofía Haselgruber-de Francisco, Javier León-Pérez

|May 20, 2025
Severity and Therapeutic Decisions Based on Lesion Location in Patients With Hidradenitis Suppurativa.

Daniel Muñoz-Barba, Sofía Haselgruber de Francisco, Francisco Javier León-Pérez

|Oct 15, 2024
Therapeutic burden in hidradenitis suppurativa: a cross-sectional study of 557 patients.

Sofía Haselgruber, Daniel Muñoz-Barba, Francisco Javier Leon-Pérez

|Aug 13, 2024
Clinical characteristics and risk factors for secondary lymphoedema in hidradenitis suppurativa.

Patricia Garbayo-Salmons, Aida Lara-Moya, Sofía Haselgruber

|Feb 27, 2024
Eligibility in a cohort of patients with hidradenitis suppurativa treated with bimekizumab: Lessons and pitfalls in a real-world setting.

C Ureña-Paniego, S Haselgruber, A Soto-Moreno

Pageof 2